Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Clinical trial NCT02307240 · COMPLETED

Trial details

NCT number: NCT02307240
Sponsor: Curis, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Triple-Negative Breast Cancer High-grade Serous Ovarian Cancer Solid Tumors NUT Midline Carcinoma

Start date: 2014-11-01
Primary completion: 2019-05-31
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.